Armistice Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Armistice Capital's BMY Position: Q3 2026 in Review
Armistice Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 233,790 shares — an estimated $13.5M sold.
Armistice Capital first reported a position in BMY in Q4 2019 and held it in 19 quarters. The position peaked at $145M in Q4 2021. 2,567 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Armistice Capital reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
- Armistice Capital sold 233,790 Bristol-Myers Squibb shares in Q3 2026, an estimated $13.5M.
- Armistice Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 19 quarters.
- Armistice Capital's Bristol-Myers Squibb position peaked at $145M in Q4 2021.
- 2,567 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.